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Acute kidney injury frequently complicates critical illness and
increases mortality; maintaining normoglycemia with insulin
has been shown to reduce the incidence of intensive care
unit (ICU)–acquired kidney injury. Here we tested the
mechanisms by which this intervention might achieve its
goal, using a rabbit model of burn-induced prolonged critical
illness in which blood glucose and insulin were
independently regulated at normal or elevated levels.
Hyperglycemia caused elevated plasma creatinine and severe
morphological kidney damage that correlated with elevated
cortical glucose levels. Renal cortical perfusion and oxygen
delivery were lower in hyperglycemic/hyperinsulinemic
rabbits, compared to other groups, but this did not explain
the elevated creatinine. Mitochondrial respiratory chain
activities were severely reduced in the hyperglycemic groups
(30–40% residual activity), and were inversely correlated with
plasma creatinine and cortical glucose. These activities were
much less affected by normoglycemia, and hyperinsulinemia
was not directly protective. Mitochondrial damage, evident at
day 3, preceded the structural injury evident at 7 days. Our
study found that hyperglycemia evoked cellular glucose
overload in the kidneys of critically ill rabbits, and this was
associated with mitochondrial dysfunction and renal injury.
Normoglycemia, independent of insulinemia, protected
against this damage.
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The development of acute kidney injury (AKI) is a frequent
complication of critical illness. Depending on the patient
population and diagnostic criteria used, its prevalence ranges
from 1 to 25%.1,2 In a large, observational, multinational
study, 5.7% of the patients had AKI at some time during their
stay in the intensive care unit (ICU), ranging from 1.4 to
25.9% across centers.3 The development of AKI requiring
renal replacement therapy is associated with a high risk of
death, generally above 50%.1,3,4 Consensus has recently been
achieved on classifying AKI based on the RIFLE (Risk of renal
dysfunction; Injury to the kidney; Failure of kidney function;
Loss of kidney function; and End-stage kidney disease)
criteria,1 shown to correlate with hospital mortality and
length of ICU and hospital stay.5
Once severe AKI has developed, supporting the patient
with renal replacement therapy to bridge time to
spontaneous recovery is the only available option to prevent
death.4 Hence, prevention of AKI is crucial, but until recently,
only hemodynamic support and avoidance of nephrotoxic
substances had shown to be effective.4,6 In two large
prospective randomized clinical studies, we showed that
strict control of blood glucose to normal levels with intensive
insulin therapy reduced the incidence of ICU-acquired
kidney injury compared with only treating excessive
hyperglycemia above 215mg per dl, besides other clinical
benefits culminating in reduced risk of death.7–9 Renal
protection appeared more pronounced in surgical than in
medical critically ill patients.10 Other (randomized)
studies and meta-analyses on the effects of insulin therapy
yielded controversial results.11–21 Generally, however,
studies that were unable to detect clinical benefit already
started with lower glucose levels in the conventional control
group than did the Leuven studies. This may suggest that
prevention of excessive hyperglycemia is what evokes the
benefit, although the combination with inadequate glucose
monitoring and poor achievement of the glycemic targets
may have a role.
Two components have been implicated in the acutely
decreased glomerular filtration rate in AKI.2 These are a
vascular component, comprising intrarenal vasoconstriction
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and endothelial damage, and a tubular component, compris-
ing tubular cellular injury and obstruction. The proximal
tubule seems particularly sensitive to mitochondrial injury,
which may have an important role in AKI. Indeed, the solute
transport activities of the kidney require substantial energy
production, and thus mitochondrial activity.22 We previously
showed a protective effect of intensive insulin therapy on the
vascular endothelium and (hepatocytic) mitochondria of
critically ill patients.23,24 This study was designed to gain
insight into the mechanisms of renal damage and protection
with intensive insulin therapy during critical illness. In
prolonged (7 days) critically ill rabbits from a previously
reported experimental study,25 we therefore investigated the
separate effect of preventing excessive hyperglycemia and
associated toxicity versus increasing insulin levels on renal
perfusion, oxygen delivery, and mitochondrial function in
relation to functional and structural kidney damage. These
analyses were complemented with a new experimental study
where we analyzed mitochondrial function and renal
structural integrity earlier in the disease course (after 3 days
of critical illness).
RESULTS
Blood glucose and insulin
According to the protocol, blood glucose and insulin levels were
independently manipulated to normal or high levels for 7 days,
resulting in four experimental groups (Table 1): normoinsuli-
nemia/normoglycemia (NI/NG), hyperinsulinemia/normogly-
cemia (HI/NG), normoinsulinemia/hyperglycemia (NI/HG),
and hyperinsulinemia/hyperglycemia (HI/HG).25 To reach these
targets, it was inevitable that glucose intake differed among the
groups (Po0.05), however, always within the physiological
range.25,26 Amounts of infused lipids and amino acids were
physiological and comparable in all groups.25
Survival and kidney injury
We previously showed that hyperglycemic animals had a
higher risk of dying before day 7 (NI/HG, 5/14¼ 35.7%; HI/
HG, 7/15¼ 46.7%) than normoglycemic rabbits (both NI/
NG and HI/NG, 1/9¼ 11.1%, P¼ 0.03).25
On day 7 of critical illness, plasma creatinine levels were
within the healthy reference range in the two normoglycemic
groups, but significantly elevated in the two hyperglycemic
groups (Figure 1a).25 This reflected a median (interquartile
range, IQR) fold change from baseline of 0.95 (0.66–1.72) for
NI/NG, 1.14 (0.72–1.81) for HI/NG, 2.08 (1.19–2.37) for NI/
HG, and 2.51 (1.51–3.88) for HI/HG. Hyperinsulinemia was
not renoprotective.
Histological examination at this time point indicated clear
morphological differences among the groups (P¼ 0.0006)
(Figure 1b). Observed abnormalities included dilatation of
the tubules, flattening or loss of tubular epithelium, and
the presence of intraluminal debris and/or calcifications
Table 1 | Blood glucose control and insulin levels
NI/NG HI/NG NI/HG HI/HG
Blood glucose (mg per dl)
Baseline 151.0±6.2 143.4±12.2 149.5±12.6 165.3±9.4
Days 1–7 92.7±1.9 84.5±5.2 328.2±16.8 314.3±11.6
Plasma insulin (mU/l)
Baseline 22.6±5.2 40.8±17.7 17.3±3.0 14.8±2.7
Days 3–7 43.3±4.1 175.8±13.1 47.3±5.2 199.8±25.9
HI/HG, hyperinsulinemia/hyperglycemia; HI/NG, hyperinsulinemia/normoglycemia;
NI/HG, normoinsulinemia/hyperglycemia; NI/NG, normoinsulinemia/normoglycemia.
Blood glucose and insulin levels were independently manipulated according to the
study design.25 Blood glucose and plasma insulin levels are presented as
mean±s.e.m. To convert glucose to mmol/l, multiply by 0.0551.
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Figure 1 |Renal damage and glucose levels. (a) Day 7 creatinine
levels. To convert values for creatinine to mmol/l, multiply by 88.4.
NI/NG (n¼ 8), HI/NG (n¼ 8), NI/HG (n¼ 9), and HI/HG (n¼ 8). Data
are presented as mean and s.e.m. The gray box indicates the
mean±s.e.m. of healthy reference ranges (n¼ 4). (b) Scoring of
morphological lesions on periodic acid-Schiff staining. Lesions
were scored ‘mild’ when a minority of tubules with flattening and/
or loss of the tubular epithelium and with intraluminal debris
were present only or mainly in the medullary rays; ‘moderate’
when a minority of tubules with flattening and/or loss of the
tubular epithelium and with intraluminal debris, whether or not
calcified, were present in the medullary rays and convoluted part
of the cortex; ‘severe’ when a conspicuous number of tubules
with flattening and/or loss of the tubular epithelium and with
intraluminal debris, whether or not calcified, were present in the
medullary rays and convoluted part of the cortex and/or cortical
necrosis was present. Numbers indicate the number of animals in
each class. (c) Glucose levels in the renal cortex are expressed per
g wet weight. NI/NG (n¼ 8), HI/NG (n¼ 8), NI/HG (n¼ 9), and HI/
HG (n¼ 8). Data are presented as mean and s.e.m. The gray box
indicates the mean±s.e.m of healthy reference ranges (n¼ 8).
#Pp0.05; &: 0.05oPp0.1 compared with healthy reference
ranges. Solid lines: Pp0.05; dashed lines: 0.05oPp0.1 between
critically ill groups.
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(Figure 2). With mild injury (observed in all sick groups),
these abnormalities were mainly present in the medullary
rays, whereas an increasing number of tubules in an extended
area (the medullary rays and convoluted part of the cortex)
were involved when damage was more severe (Figure 1b).
Necrotic areas were rare (n¼ 2). These microscopic lesions
were more severe in the two hyperglycemic than in the two
normoglycemic rabbit groups (P¼ 0.02) (Figure 1b).
Glomeruli were not affected.
Kidney glucose content
Critically ill rabbits subjected to elevated circulating glucose
levels showed substantial cellular glucose overload in the
renal cortex on day 7 (four-fold higher than the healthy
reference range, Figure 1c). When circulating levels of glucose
were maintained normal, cortical glucose levels were also
normal. Cortical glucose levels correlated positively with
plasma creatinine (R¼ 0.546, P¼ 0.0005).
Oxygen supply
We previously showed that cardiac output at the end of the
7-day experimental period was comparable for all groups.25
At that time, whole-body arterial oxygen content (CaO2) and
oxygen delivery (DaO2) were comparably low in the four sick
groups (data not shown). Perfusion, estimated by the
accumulation of microspheres, and oxygen delivery to the
cortex, was lower than the healthy reference range only in HI/
HG rabbits (Figure 3). Plasma creatinine did not correlate
with oxygen delivery to the cortex (R¼0.206; P¼ 0.3).
Rather than oxygen supply, the tissue level of glucose in the
kidney correlated with injury, as indicated by plasma
creatinine. Indeed, when both variables were entered in a
stepwise regression analysis, only glucose was maintained in
the statistical model (R¼ 0.592; P¼ 0.0004).
Mitochondrial function
At day 7, the activity of all renal cortex mitochondrial
respiratory chain enzyme complexes, except complex IV, was
low in the two groups of hyperglycemic rabbits, with residual
activities of 30–40% of healthy reference values (Figure 4).
Some enzymes appeared compromised also in normoglyce-
mic sick rabbits, but to a much lesser degree than in
hyperglycemic rabbits. Activity of complexes I, II, III, and V
wasB2-fold higher in normoglycemic than in hyperglycemic
sick rabbits. The activity of complex IV was upregulated by
illness, as seen in normoglycemic animals, but this effect was
counter-acted by hyperglycemia. Hyperinsulinemia did not
protect the mitochondria.
The level of activity of the affected mitochondrial enzymes
showed a strong inverse correlation with degree of kidney
injury (plasma creatinine), cortical glucose content, and to a
lesser degree renal cortex oxygen supply (Table 2). Impor-
tantly, however, cortical glucose content appeared the key
determinant for enzyme activity when both glucose content
and oxygen supply were entered in a stepwise regression
analysis (Table 3a). Similarly, mitochondrial damage, and not
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Figure 2 |PAS staining of paraffin sections of kidney. (a) Normal
morphology, (b) tubules with flattening and/or loss of the tubular
epithelium and filled with debris in the medullary rays, (c) tubules in
convoluted part of the cortex with flattening and/or loss of the
tubular epithelium and filled with debris, (d) tubules in the convoluted
part of the cortex with flattening and/or loss of the tubular epithelium
and with calcifications in the lumen, and (e) cortex necrosis. Original
magnification 50 (b, e), 100 (a, d), and 200 (c).
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altered oxygen supply, explained the elevated creatinine levels
(Table 3b).
Glycolysis and glycogen storage
At day 7 of critical illness, glycogen storage in the renal cortex
was increased in the two hyperglycemic rabbit groups
compared with the two normoglycemic groups and the
healthy reference values (Figure 5). HI/HG rabbits especially
had strongly elevated lactate levels in the cortex (Figure 5).
These levels correlated positively with cortical glucose
content (R¼ 0.766; Po0.0001). Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) activity was lower in hyperglyce-
mic than in normoglycemic critically ill rabbits (P¼ 0.002)
(Figure 5).
Dicarbonyls as by-products of glycolysis
On day 7, plasma levels of the dicarbonyls glyoxal
and methylglyoxal were higher in hyperglycemic than in
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Figure 4 |Mitochondrial respiratory chain enzyme activities. Activities of complexes I, II, III, IV, and V are expressed in U per g wet
weight. NI/NG (n¼ 8), HI/NG (n¼ 8), NI/HG (n¼ 9), and HI/HG (n¼ 8). HI/HG rabbits had lower protein levels than NI/NG and healthy rabbits.
Similar results were obtained for the mitochondrial enzyme activities whether they were expressed per g tissue or per mg of protein (data
not shown). Data are presented as mean and s.e.m. The gray boxes indicate the mean±s.e.m of healthy reference ranges (n¼ 4). #Pp0.05
compared with healthy reference ranges. Solid lines: Pp0.05; dashed lines: 0.05oPp0.1 between critically ill groups.
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Figure 3 |Renal perfusion and oxygen supply. Oxygen supply
to the renal cortex was calculated as the product of perfusion
estimated by the microspheres and arterial oxygen content CaO2.
In four animals, one in each of the critically ill groups, the
procedure could not be completed due to technical problems: NI/
NG (n¼ 7), HI/NG (n¼ 7), NI/HG (n¼ 8), and HI/HG (n¼ 7). All data
are presented as mean and s.e.m. The gray boxes indicate the
mean±s.e.m of healthy reference ranges (n¼ 8). #Pp0.05
compared with healthy reference ranges. Solid lines: Pp0.05;
dashed lines: 0.05oPp0.1 between critically ill groups.
Table 2 | Correlations of mitochondrial respiratory chain enzyme activities
Creatinine Glucose O2 to cortex Dicarbonyls
R P-value R P-value R P-value R P-value
Complex I 0.640 o0.0001 0.406 0.01 0.423 0.02 0.531 0.0009
Complex II 0.729 o0.0001 0.393 0.02 0.332 0.06 0.414 0.01
Complex III 0.686 o0.0001 0.498 0.002 0.264 0.1 0.421 0.01
Complex IV 0.239 0.2 0.170 0.3 0.263 0.1 0.005 40.9
Complex V 0.609 o0.0001 0.517 0.001 0.409 0.02 0.459 0.005
Table 3 | Stepwise regression analysis weighing impact of glucose, oxygen supply to the cortex, and mitochondrial respiratory
chain enzyme activities
Enzyme Variables in model Variables not in model |R| P-value
(a) Impact of glucose and oxygen supply on mitochondrial enzyme activities
Complex I Glucose, O2 to cortex — 0.552 0.005
Complex II Glucose O2 to cortex 0.441 0.01
Complex III Glucose O2 to cortex 0.463 0.008
Complex IV — Glucose, O2 to cortex — —
Complex V Glucose O2 to cortex 0.517 0.002
(b) Impact of oxygen supply and mitochondrial enzyme activities on creatinine levels
Complex I Complex I O2 to cortex 0.551 0.001
Complex II Complex II O2 to cortex 0.605 0.0002
Complex III Complex III O2 to cortex 0.607 0.0002
Complex IV — C IV, O2 to cortex — —
Complex V Complex V O2 to cortex 0.528 0.002
Whereas in (a) mitochondrial enzyme complexes in the first column indicate the outcome variable in the analysis, in (b) entries in the first column denote the mitochondrial
enzyme that was entered into the model together with oxygen supply to the cortex.
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normoglycemic critically ill (P¼ 0.006) and healthy rabbits
(P¼ 0.006) (Figure 6). These levels correlated positively with
cortical glucose content (R¼ 0.679; Po0.0001) and plasma
creatinine (R¼ 0.519; P¼ 0.001) and inversely with mito-
chondrial respiratory chain enzyme activities (Table 2). The
glyoxalase pathway, responsible for detoxification of dicar-
bonyls, was evaluated by the activity of the glyoxalases and
reduced glutathione as a co-factor of glyoxalase I (Figure 6).
Glyoxalase I activity was decreased by critical illness, except in
NI/NG rabbits. Glyoxalase II activity was significantly
reduced only in HI/HG rabbits. Levels of reduced glutathione
were lower in HI/HG rabbits than in healthy and normogly-
cemic sick rabbits.
Effect of hyperglycemia on kidney morphology and
mitochondria after 3 days of critical illness
To address the sequence in which mitochondrial abnormal-
ities and morphological kidney injury occurred, we studied
the effect of hyperglycemia (HI/NG) compared with that of
normoglycemia (HI/HG) on these parameters after 3 days of
critical illness. All rabbits survived the preset time course.
Mean blood glucose levels were 94.4±6.2mg per dl in the
normoglycemic group and 318.6±6.8mg per dl in the
hyperglycemic group (Po0.0001). Creatinine levels were
comparable for the two groups at baseline (P¼ 0.4), but were
higher on day 3 in the hyperglycemic rabbits than in the
normoglycemic rabbits (ratio of 1.73±0.10 versus
1.00±0.06, P¼ 0.0002). Whereas hyperglycemic rabbits had
severe structural kidney injury at day 7, morphology was
normal at day 3. In contrast, mitochondrial respiratory chain
complexes I and V were affected in the hyperglycemic rabbits
already at day 3, although to a lesser extent than on day 7,
which was prevented or attenuated by maintaining normo-
glycemia (Figure 7). Complex I (R¼ 0.519, P¼ 0.047) and
complex V (R¼ 0.585, P¼ 0.02) activities correlated with
mean blood glucose levels. These data suggest that hypergly-
cemia-induced mitochondrial abnormalities precede struc-
tural kidney damage.
DISCUSSION
Our rabbit model of prolonged critical illness showed renal
dysfunction, indicated by elevated plasma levels of creatinine.
By independent manipulation of blood glucose and insulin
levels in these rabbits, we indicated that maintaining
normoglycemia during critical illness protected the kidney,
whereas elevated insulin levels did not. Kidney protection was
not explained by better perfusion or oxygen delivery to the
kidney, but rather prevention of hyperglycemia-induced
mitochondrial dysfunction may be involved. Indeed, main-
tenance of normal blood glucose levels prevented cellular
glucose overload in the renal cortex, correlating with better
preservation of mitochondrial function, which, in turn,
correlated with prevention of renal dysfunction.
Blood glucose levels spontaneously increase in our rabbit
model of critical illness.27 Comparable with critically ill
patients, these rabbits also develop renal injury as evidenced
by elevated plasma creatinine levels in the hyperglycemic
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Figure 5 | Evaluation of glucose storage and glycolysis. Glycogen levels are expressed as amount of glucose released from glycogen
per g wet weight. Levels of lactate are expressed per g wet weight, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) activity is
expressed in U per g wet weight. NI/NG (n¼ 8), HI/NG (n¼ 8), NI/HG (n¼ 9), and HI/HG (n¼ 8). All data are presented as mean and s.e.m.
The gray boxes indicate the mean±s.e.m of healthy reference ranges (n¼ 4–8). #Pp0.05 compared with healthy reference ranges. Solid
lines: Pp0.05; dashed lines: 0.05oPp0.1 between critically ill groups.
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Figure 6 |Metabolism of dicarbonyls. Dicarbonyl levels were
measured in plasma. Reduced glutathione levels in the cortex are
expressed per g wet weight and enzymatic activities of glyoxalase
I and II are expressed in U per g wet weight. NI/NG (n¼ 8), HI/NG
(n¼ 8), NI/HG (n¼ 9), and HI/HG (n¼ 8). All data are presented as
mean and s.e.m. The gray boxes indicate the mean±s.e.m of
healthy reference ranges (n¼ 4–8). #Pp0.05 compared with
healthy reference ranges. Solid lines: Pp0.05; dashed lines:
0.05oPp0.1 between critically ill groups.
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animals, coinciding with severe morphological abnormalities
at the level of the tubuli. Although this condition of AKI is
often designated as ‘acute tubular necrosis,’ frank necrosis
appears uncommon.2,28 Also in our animal model, necrosis
was rare. The rabbits, similar to critically ill patients, did not
develop glomerular abnormalities. Similar to patients with
AKI,29 the medullary rays appeared particularly susceptible
(possibly due to local hypoxia) as with the mildest damage
only this region was affected, with progressive involvement of
the total cortex (the medullary rays and the convoluted part)
with increasing severity. Mild damage was observed in all
critically ill rabbit groups. Importantly, the increase in
creatinine and severe morphological damage observed in
the hyperglycemic ill rabbits was counteracted by main-
tenance of normal blood glucose levels during critical illness,
which protected against cortical glucose overload. Further-
more, a direct correlation was observed between glucose
levels in the cortex and plasma creatinine levels. In contrast,
hyperinsulinemia was not able to protect the kidney. These
data illustrate that blood glucose control, but not insulin by
itself, is renoprotective during critical illness.7–10 The
importance of achieving normoglycemia had been suggested
earlier by a post-hoc analysis of the Leuven clinical
studies.9,10,30 Conclusions regarding a direct effect of insulin
or of blood glucose control on kidney could, however, not be
drawn, possibly obscured by more severe insulin resistance in
the sicker patients as a confounding factor. Indeed, insulin
requirement was higher in patients with ICU-acquired
RIFLE-Injury or RIFLE-Failure, those with a need for renal
replacement therapy, and oliguria.10
Despite the high blood flow to and low oxygen extraction
by healthy kidneys, these organs are particularly susceptible
to hypoxic injury.31 Hemodynamic alterations resulting in
reduced blood flow to the kidney are important in the
etiology of AKI.2,28 Therefore, optimizing the volume status
with adequate fluid therapy and cardiac output to assure
blood flow and systemic oxygen delivery is of crucial
importance, although frequently appears insufficient to
prevent renal dysfunction as well as failure of other organs
in critically ill patients. Similarly, AKI developed in our
animal model, despite adequate fluid resuscitation during the
entire study period. The vascular endothelium has a function
in regulating microvascular blood flow and oxygen delivery
to tissues, and we previously showed endothelial protection
by blood glucose control with intensive insulin therapy in
patients.23 We hypothesized that an effect of glucose control
or insulin on perfusion and oxygen delivery may have
contributed to improved renal outcome in our rabbit model.
Critical illness reduced cortical perfusion and oxygen delivery
only in the presence of hyperglycemia with concomitant
hyperinsulinemia. However, this effect did not explain renal
damage.
Renal function strongly correlated with the mitochondrial
respiratory chain enzyme activities. These were severely
affected by hyperglycemia and protected by strict blood
glucose control that also normalized the tissue levels of
glucose. Hyperinsulinemia was not directly protective to the
mitochondria. A few decades ago, a study on kidneys of
third-degree burn-injured rats had shown severely reduced
mitochondrial respiration and phosphorylative activity,
which could be restored by subcutaneous administration of
insulin.32 However, this study could not discriminate
between a role for glycemic control and direct insulin effects.
Furthermore, the protection of the kidney and its mitochon-
dria in our study was independent of tissue perfusion and
oxygen delivery. Our findings are in agreement with previous
studies supporting a role for inadequate mitochondrial
oxygen utilization or ‘cytopathic hypoxia,’ rather than (or
in addition to) oxygen delivery, in the altered oxygen
metabolism observed in various tissues during critical
illness.33–39 A pivotal role of mitochondrial, bioenergetic
abnormalities in renal failure during critical illness is
plausible, as the kidney needs a large amount of energy for
reabsorption of fluid and solutes across the renal tubular
epithelium.22 Particularly, the proximal tubule appears very
sensitive to mitochondrial injury. The mitochondrial ab-
normalities in the critically ill rabbits did not develop
secondary to major structural injury, as mitochondrial
respiratory chain activity reductions preceded structural
alterations, further supporting the involvement of mitochon-
drial damage in the pathophysiology of hyperglycemia-
induced kidney injury.
The mechanisms underlying rapid glucose toxicity to
mitochondria and kidney in critical illness remain incom-
pletely understood. A number of pathways are known to be
activated in the hyperglycemic milieu and have been
suggested to contribute to hyperglycemic damage in diabetes
mellitus. One of these pathways involves dicarbonyls,
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Figure 7 |Mitochondrial respiratory chain enzyme activities after 3 days of critical illness. Activities of complex I, II, III, IV, and V are
expressed in U per g wet weight. HI/NG (n¼ 5) and HI/HG (n¼ 5). Data are presented as mean and s.e.m. The gray boxes indicate the
mean±s.e.m. of healthy reference ranges (n¼ 5). #Pp0.05 compared with healthy reference ranges. Solid line: Pp0.05; dashed line:
0.05oPp0.1 between critically ill groups.
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which are spontaneously formed as metabolites of glucose
and are highly reactive with proteins.40 Elevated dicarbonyl
levels are observed in diabetes,41 mimic diabetic complica-
tions when administered in the presence of normoglycemia,42
and act as mitochondrial toxins in the kidney or other
tissues.43–46 In the kidney of a diabetes rat model, specific
mitochondrial proteins appeared post-translationally mod-
ified by dicarbonyls, of which the extent correlated with
progressively compromised mitochondrial bioenergetics.46
The critically ill hyperglycemic rabbits in our study had
elevated dicarbonyl levels compared with normoglycemic
rabbits, which correlated with mitochondrial damage and
renal dysfunction and hence may point to a contribution to
the pathogenesis of kidney damage in critical illness.
Dicarbonyls may accumulate secondary to inactivation of
the glycolytic enzyme, GAPDH, by hyperglycemia that blocks
glycolysis and shifts glucose into proximal toxic pathways47
or, alternatively, by increased glucose flux through the
glycolytic pathway that proportionally increases its diversion
into these toxic pathways.48 A small decrease was observed in
the activity of GAPDH in the cortex of hyperglycemic
rabbits. However, the parallel increase in the tissue levels of
lactate, strongly correlating with glucose content, suggests
that glycolytic flux was not compromised, but rather
increased. Such increased formation of lactate due to
increased glucose turnover and higher production of
pyruvate has previously been shown in critically ill
patients,49,50 despite the fact that a classical dogma links
hyperlactatemia in critical illness to inadequate tissue
oxygenation or to impaired clearance.
Although our burn-injured rabbit model of critical illness
mimics the human stress response to severe trauma,51
inherent limitations need to be considered when working
with animal models in view of extrapolation to patients and
generalizability of the findings. Without active glucose
control, burn injury in our animal model spontaneously
results in the degree of hyperglycemia in this study.27
However, although such high glucose levels are still observed
in certain patient populations and used in experimental
studies,52–54 they are not currently tolerated in critically ill
patients in general. Avoiding excessive hyperglycemia may be
key to obtain renal and other clinical benefits of intensive
insulin therapy, as observed in the Leuven studies,7–10
and suggested by the present animal data. Whether blood
glucose should be controlled to strict normoglycemia, as
done in the Leuven studies, or rather to an intermediate
target range should be further studied using appropriate
glucose-monitoring tools.7–21 A certain bias may have
been introduced to our animal study by arbitrarily choosing
a 7-day time course of critical illness, in view of the
potential dynamic character of the changes and the study of
survivors only (to avoid interference by post-mortem
artifacts), that excluded the most severely ill animals
from the analyses. However, such selection due to the
higher mortality of hyperglycemic animals would under-
estimate rather than overestimate the observed differences
between the normoglycemic and hyperglycemic rabbit
groups. Furthermore, we have largely circumvented these
limitations by also analyzing a time course of 3 days of
critical illness, already showing discrete mitochondrial
alterations early in the disease, in the absence of mortality
as a confounding factor. Owing to technical reasons, urine
could not be collected during the study, hampering further
characterization of the renal dysfunction (e.g., by determin-
ing urine output and calculating glomerular filtration rate).
However, qualitative deterioration of glomerular filtration
rate could be evaluated by change in creatinine levels in the
course of the disease.1 Finally, analyses were inevitably
performed on small pieces of tissue, which theoretically
may have detected regional differences rather than alterations
at the whole organ level.
In conclusion, hyperglycemia evoked cellular glucose
overload in the kidney of critically ill rabbits and induced
mitochondrial dysfunction and renal injury. Maintenance of
normoglycemia, independent of insulinemia, protected
against such a cascade of damage to the kidney.
MATERIALS AND METHODS
Experimental rabbit study
This study was largely performed on plasma and tissue
samples obtained during a previously reported experimental
study25 in a well-characterized standardized, fluid-resuscitated,
third-degree burn injury model of critical illness. The study was
approved by the Leuven University Ethical Review Board for Animal
Research (P04058). All animals were treated according to the
Principals of Laboratory Animal Care formulated by the US National
Society for Medical Research and the Guide for the Care and Use of
Laboratory Animals prepared by the US National Institutes of
Health.
The study protocol has been described in detail elsewhere.25 In
adult, 3- to 4-month-old male New Zealand white rabbits weighing
B3 kg, endogenous insulin production was eliminated with alloxan
(150mg/kg injected slowly by a marginal ear vein on day 1). At
day 0, catheters were placed in the right jugular vein for intravenous
infusion of insulin/total parenteral nutrition and in the right carotid
artery for blood sampling, followed by application of a full thickness
20% body surface area third-degree burn injury, all under general
anesthesia (30mg/kg ketamine, intramuscularly, 0.15ml/kg mede-
tomidine intramuscularly, 1.5% isoflurane inhalation). A paraver-
tebral block was performed with 5ml 1% xylocaine before burn
injury. These critically ill rabbits were randomized to glucose control
to normal (80–110mg per dl, NG) or high levels (250–350mg per dl,
HG). For each glucose level, insulin was clamped to normal (1.2U/
kg/day infused, NI) or high levels (4U/kg/day infused, HI): NI/NG
(n¼ 8), HI/NG (n¼ 8), NI/HG (n¼ 9), and HI/HG (n¼ 8).
Animals were fluid resuscitated by infusion of the 18ml/h
Hartmann solution supplemented with 3.4% glucose. During the
experimental period, the two preset levels of glycemia were reached
by adjusting a continuous 50% glucose infusion supplementing
basal glucose intake. At day 1, the Hartmann solution was replaced
by parenteral nutrition infused at 12ml/h, which was changed daily
until day 7. The amount of nutrition given was recorded daily. The
study was continued until in each group eight animals survived to
day 7. Animals were fluid resuscitated throughout the 7-day study
period.
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On day 7, animals were anesthetized and normoventilated
through tracheostomy. Normovolemia was maintained by infusion
of 6ml/h of Hartmann solution. The carotid artery catheter
(previously placed for blood sampling) was advanced into the left
ventricle, guided by the pressure curve. Hemoglobin, pO2 (paO2),
pCO2, and oxygen saturation (SaO2) were determined in arterial
blood samples and cardiac output was recorded as described.25
Arterial oxygen content CaO2 (hemoglobin 1.36 SaO2þ paO2
 0.0031) and delivery DaO2 (cardiac outputCaO2) were
calculated. Perfusion of the kidneys was evaluated using colored
Dye-Trak microspheres according to a previously published protocol
(Triton Technology, San Diego, CA, USA).55 To this end, a fluid-
filled catheter was inserted 3 cm deep through the carotic artery into
the circle of Willis. The catheter was connected to a glass syringe
mounted in a precision pump (Harvard Pump 11, Harvard
Apparatus, Holliston, MA, USA) for withdraw of a reference
sample. The withdraw pump was started at 1ml/min, and 10 s later,
3 million microspheres with highly uniform size distribution
(15.00±0.45 mm) in a 1-ml volume were injected over 10 s through
the left ventricular catheter. The line was then flushed for 40 s with
Hartmann solution, and 60 s later, the pump stopped yielding a
reference sample at 120 s, which was stored at 4 1C until analysis.
After this procedure, slices of kidney and biopsies from the renal
cortex were taken and snap-frozen in liquid nitrogen for long-term
storage or stored at 4 1C for recovery of microspheres. Animals were
killed by cutting out the heart.
Microspheres were recovered from the tissue and blood samples
by KOH digestion and filtration through 8 mm filters.55 The dye was
extracted from the microspheres in 100 ml dimethylformamide and
its concentration determined in a spectrophotometer.55 Recovery of
microspheres from the reference sample was used to calculate
absolute organ blood flow. Equal perfusion of the left and right
kidney was used as a quality control. Oxygen supply was calculated
as the product of perfusion estimated by the microspheres and
CaO2.
As a reference, data and tissue biopsies from healthy rabbits were
obtained and stored similarly as for the critically ill rabbits. These
rabbits did not receive alloxan and burn injury, were not
catheterized, and had free access to standard chow.
To assess early effects of hyperglycemia, we designed a second
animal study, where we created two groups relevant to the human
condition and killed the animals after 3 days of critical illness.
During the 3-day time course, the rabbits were controlled to either
normoglycemia or hyperglycemia with concomitant hyperinsuline-
mia (HI/NG, n¼ 5 and HI/HG, n¼ 5, respectively), to mimick the
clinical condition of critically ill patients (elevated insulin levels
regardless of insulin therapy56). Slices of kidney and biopsies from
the renal cortex of these ill as well as healthy rabbits (n¼ 5) were
taken and stored at 80 1C as described.
Biochemical analyses
Plasma creatinine was measured on day 7 by routine clinical
chemistry (Jaffe´ method). Renal structure was investigated by light
microscopy after periodic acid-Schiff staining of paraffin sections.
Activities of the mitochondrial respiratory chain enzyme complexes
I–V were measured as described.24 The levels of glucose, lactate,
glycogen, and glutathione57,58 and the activities of GAPDH
and glyoxalase I and II24,59 were quantified by spectrophotometric
assays. Dicarbonyls (glyoxal and methylglyoxal) were quantified by
mass spectrometry.60 All analyses were carried out blinded to
treatment.
Statistical analysis
Results are presented as mean and s.e.m. Differences among study
groups were analyzed by multifactorial ANOVA and Fisher’s
protected least-significant difference post-hoc testing for comparison
of normally distributed data and by the Kruskall–Wallis and
Mann–Whitney U-test for not-normally distributed data. Correla-
tions between parameters were studied by linear, logarithmic, or
stepwise regression analysis. Differences were considered statistically
significant when two-sided P-values werep0.05. Statistical analyses
were carried out using StatView 5.0.1 for Macintosh (SAS Institute,
Cary, NC, USA).
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